Digital Pathology News and Research

RSS

3DHISTECH at the Comenius University in Slovakia

The Ministry of Health of Slovakia, in cooperation with the Slovak Society of Pathologists, organized a Presentation Day of Digital Pathology Solutions at Comenius University in Bratislava.

From 3DHISTECH Ltd. 25 Sep 2023

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation Incubator in Budapest to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions.

From 3DHISTECH Ltd. 25 Sep 2023

Digital pathology technology set to transform medical diagnosis

Patients will receive faster and more accurate pathology results following a decade-long research project that is set to transform medical diagnosis.

20 Jul 2023

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

3DHISTECH is thrilled to announce its recent collaboration with Quantmetry.

From 3DHISTECH Ltd. 22 Jun 2023

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

3DHISTECH is thrilled to announce its recent collaboration with Quantmetry.

22 Jun 2023

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia have identified new biomarkers for non-small cell lung cancer, the most common lung cancer.

20 Jun 2023

Innovative approach for detecting pre-cancerous lesions using large, high-res images

A new study presents an innovative approach to the crucial detection of pre-cancerous lesions using large, high-res images.

1 Jun 2023

Unraveling Nature's Complexity with Molecular Imaging

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Ron Heeran, a speaker at the 2023 James L. Waters Symposium.

From Pittcon 1 May 2023

SpatialOMx - Mass Spectrometry and the Future of Spatial Biology

In this interview, Bruker speaks with Ramon Sun on the topic of SpatialOMx - a field that is currently experiencing great changes. Dive in to discover how Bruker will rise to the challenge.

From Bruker Life Sciences Mass Spectrometry 17 Mar 2023

Veterans’ health administration expands deployment of Mikroscan Systems

Mikroscan Technologies, innovators and manufacturers of live robotic microscopy and whole-slide imaging (WSI) systems, announces that it has expanded its relationship with the Veterans’ Administration through the multi-system sale of its SL5-20 Real-Time Telemicroscopy and Digital Pathology systems.

From Mikroscan Technologies 14 Mar 2023

What is the role of B cells in breast cancer pathology?

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer.

1 Mar 2023

Fujifilm announces asset purchase agreement with Inspirata, Inc. to acquire the company’s digital pathology business

FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced the company has entered into an asset purchase agreement to acquire the global digital pathology business of Tampa, Florida-based Inspirata, Inc. Upon completion of this agreement, Inspirata's Dynamyx® digital pathology technology, employees and customers will become part of Fujifilm.

From FUJIFILM Corporation 20 Dec 2022

New partnership creates an automated anatomic pathology slide-scanning solution

Sakura Finetek, a global leader in histopathology products and Evident Scientific, a wholly owned subsidiary of Olympus Corporation, and a global leader in microscopy and imaging solutions, today announced a collaboration to offer a full workflow solution for anatomic pathology slide preparation and high-resolution digital scanning in the Americas.

From Evident Corporation 13 Oct 2022

AI-based pathology diagnosis tool in development detects 7 types of gastric cancer

Evident, a wholly owned subsidiary of Olympus Corporation, announced the latest results from its ongoing joint research program to create an AI-based pathology diagnostic tool at the 20th annual meeting of the Japanese Society of Digital Pathology.

From Evident Corporation 13 Sep 2022

FUJIFILM Corporation Commit Themselves to Digital Pathology

FUJIFILM Corporation is at the forefront of the digital histopathology revolution, centered around the Dynamyx™ software by Inspirata, and supported by genuine partnerships that drive improvements in patient care.

From FUJIFILM Corporation 22 Jun 2022

Novel AI algorithm developed for assessing digital pathology data

Digital pathology is an emerging field which deals with mainly microscopy images that are derived from patient biopsies.

23 May 2022

Sectra signs digital pathology contract with Erasmus MC

International medical imaging IT and cybersecurity company Sectra has signed a digital pathology contract with Erasmus University Medical Center (Erasmus MC) in the Netherlands.

21 Mar 2022

Multi-institutional teams awarded grant support from the Starr Cancer Consortium

Two multi-institutional teams led by Weill Cornell Medicine scientists have been awarded grant support from the Starr Cancer Consortium. Both grants will fund work applying new technologies to develop more detailed knowledge of tumor biology, with one team focusing on Hodgkin lymphoma and the other on the purity of tumor samples on pathology slides.

10 Mar 2022

Olympus announces first results of its AI-based pathology diagnostic tool for gastric cancer

The results of Olympus’ ongoing joint research program to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were announced at the Japan Society of Digital Pathology Study annual meeting.

From Evident Corporation 17 Nov 2021

Researchers release guidance to address pathology aspects in clinical trial protocols

An international group of cancer researchers, led by the National Cancer Research Institute's (NCRI) Cellular Molecular Pathology Initiative (CMPath), has published guidance to address the variability in how pathology is planned and delivered in clinical trials.

28 Sep 2021

Digital Pathology News and Research

3DHISTECH at the Comenius University in Slovakia

3DHISTECH and Epredia open pathology innovation incubator to accelerate advancements in cancer diagnostics

Digital pathology technology set to transform medical diagnosis

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

Quantmetry also uses SimpleSlideInterface by 3DHISTECH

Pioneering methodology reveals novel biomarkers for non-small cell lung cancer

Innovative approach for detecting pre-cancerous lesions using large, high-res images

Unraveling Nature's Complexity with Molecular Imaging

SpatialOMx - Mass Spectrometry and the Future of Spatial Biology

Veterans’ health administration expands deployment of Mikroscan Systems

What is the role of B cells in breast cancer pathology?

Fujifilm announces asset purchase agreement with Inspirata, Inc. to acquire the company’s digital pathology business

New partnership creates an automated anatomic pathology slide-scanning solution

AI-based pathology diagnosis tool in development detects 7 types of gastric cancer

FUJIFILM Corporation Commit Themselves to Digital Pathology

Novel AI algorithm developed for assessing digital pathology data

Sectra signs digital pathology contract with Erasmus MC

Multi-institutional teams awarded grant support from the Starr Cancer Consortium

Olympus announces first results of its AI-based pathology diagnostic tool for gastric cancer

Researchers release guidance to address pathology aspects in clinical trial protocols

Breaking Barriers: ANDYSMANCLUB's Fight for Men's Mental Health on World Mental Health Day

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Latest Life Science News